Semaglutide
Take control of your appetite and transform your body with proven science.
Read the full Semaglutide profileThe two most-searched GLP-1 peptides, side by side — how they act on the body, how they're dosed and titrated, and who each one tends to suit.
This page compares the same profile fields for both. It does not decide which is better, recommend either compound, or determine whether switching or combining them is appropriate.
Take control of your appetite and transform your body with proven science.
Read the full Semaglutide profileThe ultimate FDA-approved weight loss solution. Lose 20%+ of your body weight.
Read the full Tirzepatide profileSemaglutide is an FDA-approved GLP-1 receptor agonist that has transformed treatment of obesity and type 2 diabetes. It works by mimicking the hormone GLP-1 to reduce appetite, slow stomach emptying, and improve insulin sensitivit...
Tirzepatide is a dual peptide that mimics GLP-1 and GIP to powerfully suppress appetite, slow digestion, and improve insulin sensitivity, helping many people lose significant weight and control blood sugar.
FDA-approved with well-characterized side effects. GI issues are common but manageable.
Contraindicated in medullary thyroid cancer or MEN 2 syndrome. May cause pancreatitis. Do not mix in the same syringe as other peptides. Inject GLP-1s on their own.
FDA-approved with extensive clinical trial data. Well-characterized side effect profile.
Common GI side effects typically improve over 4-8 weeks. Titrate slowly to minimize nausea. Not for Type 1 diabetes. Do not mix in the same syringe as other peptides. Inject GLP-1s on their own.
Injection: Start 0.25 mg weekly, titrate to 1-2.4 mg weekly. Oral: Start 3 mg daily, up to 14 mg daily
weekly
Ongoing as prescribed
Titrate slowly over months to minimize GI side effects; take oral on empty stomach
2.5 mg weekly, titrating up every 4 weeks
weekly
12-24 weeks per treatment cycle
Start at 2.5 mg and increase slowly (every 4 weeks) to minimize GI side effects. Take at the same time each week.
The rows above pull from the live peptide profile data used across The Peptide App. Use the comparison to spot differences in documented profile context, titration notes, and safety flags. Missing data remains missing rather than being inferred.
Semaglutide is summarized as: Take control of your appetite and transform your body with proven science. Tirzepatide is summarized as: The ultimate FDA-approved weight loss solution. Lose 20%+ of your body weight.
Comparison questions are personal and context-dependent, so these answers stay educational instead of recommending a protocol.
Semaglutide and Tirzepatide are distinct compounds and can differ in mechanism, documented profile context, titration notes, evidence, and safety flags. The comparison table shows the same stored fields side by side and leaves unavailable information blank.
There is no universal answer, and this page does not rank or recommend either compound. A licensed professional can interpret the evidence, product status, and individual context; this page is only a structured research comparison.
Combining peptides can change dosing complexity and risk. This comparison is not medical advice, and it should not be used to start, stop, or combine protocols. A licensed professional is the right person to evaluate whether any combination is appropriate.
This comparison is for research and educational purposes. It does not diagnose, treat, prescribe, or replace guidance from a licensed professional. Always follow the instructions provided with your product.
Keep dose timing, reminders, and protocol notes in one place after you decide what you want to track.
Open either peptide profile, browse the peptide library, or compare another pair.